These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19243319)

  • 1. Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids.
    Fenger-Eriksen C; Tønnesen E; Ingerslev J; Sørensen B
    Acta Anaesthesiol Scand; 2009 Mar; 53(3):332-8. PubMed ID: 19243319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro.
    Darlington DN; Delgado AV; Kheirabadi BS; Fedyk CG; Scherer MR; Pusateri AE; Wade CE; Cap AP; Holcomb JB; Dubick MA
    J Trauma; 2011 Nov; 71(5):1152-63. PubMed ID: 21610535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate artificially masks the haemostatic effect of recombinant factor VIIa in dilutional coagulopathy.
    Fenger-Eriksen C; Ingerslev J; Tønnesen E; Sørensen B
    Ann Hematol; 2009 Mar; 88(3):255-60. PubMed ID: 18696068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.
    Sørensen B; Ingerslev J
    Thromb Haemost; 2006 Oct; 96(4):446-53. PubMed ID: 17003921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.
    Larsen OH; Stentoft J; Radia D; Ingerslev J; Sørensen B
    Br J Haematol; 2013 Jan; 160(2):228-36. PubMed ID: 23151086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates.
    Caballo C; Escolar G; Diaz-Ricart M; Lopez-Vílchez I; Lozano M; Cid J; Pino M; Beltrán J; Basora M; Pereira A; Galan AM
    Blood Transfus; 2013 Jul; 11(3):391-9. PubMed ID: 23058866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven).
    Viuff D; Lauritzen B; Pusateri AE; Andersen S; Rojkjaer R; Johansson PI
    Br J Anaesth; 2008 Sep; 101(3):324-31. PubMed ID: 18565966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy.
    Hanna J; Winstedt D; Schött U
    Scand J Clin Lab Invest; 2013 Oct; 73(7):553-62. PubMed ID: 24004348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free oscillation rheometry monitoring of haemodilution and hypothermia and correction with fibrinogen and factor XIII concentrates.
    Winstedt D; Tynngård N; Olanders K; Schött U
    Scand J Trauma Resusc Emerg Med; 2013 Mar; 21():20. PubMed ID: 23517637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
    Tanaka KA; Taketomi T; Szlam F; Calatzis A; Levy JH
    Anesth Analg; 2008 Mar; 106(3):732-8, table of contents. PubMed ID: 18292410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures.
    Kheirabadi BS; Delgado AV; Dubick MA; Scherer MR; Fedyk CG; Holcomb JB; Pusateri AE
    J Trauma; 2007 Nov; 63(5):1079-86. PubMed ID: 17993954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate.
    Fenger-Eriksen C; Anker-Møller E; Heslop J; Ingerslev J; Sørensen B
    Br J Anaesth; 2005 Mar; 94(3):324-9. PubMed ID: 15608046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery.
    Sørensen B; Asvaldsdottir HS; Gudmundsdottir BR; Onundarson PT
    Thromb Res; 2009 Dec; 124(6):695-700. PubMed ID: 19733387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of recombinant factor VIIa under different conditions in vitro: effect of temperature, pH, and haemodilution.
    Bladbjerg EM; Jespersen J
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):369-74. PubMed ID: 18600084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring recombinant factor VIIa treatment: efficacy depends on high levels of fibrinogen in a model of severe dilutional coagulopathy.
    Ganter MT; Schmuck S; Hamiel CR; Wischmeyer PE; Heule D; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):675-80. PubMed ID: 18922422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
    Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions.
    Ogawa S; Ohnishi T; Hosokawa K; Szlam F; Chen EP; Tanaka KA
    Br J Anaesth; 2013 Dec; 111(6):1013-23. PubMed ID: 23794670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%.
    De Lorenzo C; Calatzis A; Welsch U; Heindl B
    Anesth Analg; 2006 Apr; 102(4):1194-200. PubMed ID: 16551923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticagrelor reversal:
    Calmette L; Martin AC; Le Bonniec B; Zlotnik D; Gouin-Thibault I; Bachelot-Loza C; Gaussem P; Godier A
    J Clin Pathol; 2017 Sep; 70(9):733-739. PubMed ID: 28159767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.